Roberta Alfieri

5.4k total citations · 1 hit paper
122 papers, 4.1k citations indexed

About

Roberta Alfieri is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Roberta Alfieri has authored 122 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 63 papers in Pulmonary and Respiratory Medicine and 51 papers in Oncology. Recurrent topics in Roberta Alfieri's work include Lung Cancer Treatments and Mutations (41 papers), PI3K/AKT/mTOR signaling in cancer (20 papers) and HER2/EGFR in Cancer Research (17 papers). Roberta Alfieri is often cited by papers focused on Lung Cancer Treatments and Mutations (41 papers), PI3K/AKT/mTOR signaling in cancer (20 papers) and HER2/EGFR in Cancer Research (17 papers). Roberta Alfieri collaborates with scholars based in Italy, United Kingdom and Netherlands. Roberta Alfieri's co-authors include Pier Giorgio Petronini, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Silvia La Monica, Marcello Tiseo, Maricla Galetti, Angelo F. Borghetti, Daniele Cretella and Andrea Ardizzoni and has published in prestigious journals such as Nano Letters, PLoS ONE and The Journal of Physiology.

In The Last Decade

Roberta Alfieri

120 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer

2014 390 citations Claudia Fumarola, Mara Bonelli et al. Biochemical Pharmacology profile →

Peers

Countries citing papers authored by Roberta Alfieri

Since Specialization

Citations

This map shows the geographic impact of Roberta Alfieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Alfieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Alfieri more than expected).

Fields of papers citing papers by Roberta Alfieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Alfieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Alfieri. The network helps show where Roberta Alfieri may publish in the future.

Co-authorship network of co-authors of Roberta Alfieri

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Alfieri. A scholar is included among the top collaborators of Roberta Alfieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Alfieri. Roberta Alfieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators 2023 ·Targeted Oncology ·Francesco Volta, Silvia La Monica, Alessandro Leonetti, Letizia Gnetti, Mara Bonelli, Andrea Cavazzoni, Claudia Fumarola, Maricla Galetti, (unknown), Roberta Minari, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri	8
2	A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 2023 ·International Journal of Molecular Sciences ·Maria Pia Adorni, Maricla Galetti, Silvia La Monica, Matteo Incerti, Alessandro Ruffoni, Lisa Elviri, Ilaria Zanotti, Bianca Papotti, Delia Cavallo, Roberta Alfieri, Pier Giorgio Petronini, Franco Bernini	8
3	Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer 2022 ·Cells ·(unknown), Silvia La Monica, Marcello Tiseo, Roberta Alfieri, Claudia Fumarola	48
4	A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine 2021 ·European Journal of Medicinal Chemistry ·Francesca Ferlenghi, Laura Scalvini, Federica Vacondio, Riccardo Castelli, (unknown), (unknown), Silvia Rivara, Alessio Lodola, Silvia La Monica, Roberta Minari, Pier Giorgio Petronini, Roberta Alfieri, Marcello Tiseo, Marco Mor	40
5	FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy 2020 ·Cancer Research ·Nicola Manfrini, Marilena Mancino, Annarita Miluzio, Stefania Oliveto, (unknown), Piera Calamita, Roberta Alfieri, Riccardo L. Rossi, Marco Sassoé‐Pognetto, Chiara Salio, Alessandro Cuomo, Tiziana Bonaldi, Marcello Manfredi, Emílio Marengo, Elia Ranzato, Simona Martinotti, Davide Cittaro, Giovanni Tonon, Stefano Biffo	32
6	Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer 2020 ·Cancers ·Andrea Cavazzoni, Graziana Digiacomo, Roberta Alfieri, Silvia La Monica, Claudia Fumarola, Maricla Galetti, Mara Bonelli, Daniele Cretella, Valeria Barili, Alessandra Zecca, Elisa Giovannetti, Michelangelo Fiorentino, Marcello Tiseo, Pier Giorgio Petronini, Andrea Ardizzoni	36
7	Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion 2019 ·Targeted Oncology ·Silvia La Monica, Roberta Minari, Daniele Cretella, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Maricla Galetti, Graziana Digiacomo, Federica Riccardi, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri	38
8	A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma 2018 ·Cancer Research ·Stefania Oliveto, Roberta Alfieri, Annarita Miluzio, Alessandra Scagliola, (unknown), Pierluigi Gasparini, Stefano Grosso, Luciano Cascione, Luciano Mutti, Stefano Biffo	28
9	Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models 2018 ·Journal of Thoracic Oncology ·Carminia Maria Della Corte, Vincenza Ciaramella, Claudia Cardone, Silvia La Monica, Roberta Alfieri, Pier Giorgio Petronini, Umberto Malapelle, Elena Vigliar, Francesco Pepe, Giancarlo Troncone, Maria Domenica Castellone, Teresa Troiani, Erika Martinelli, Fortunato Ciardiello, Floriana Morgillo	31
10	SBDS-Deficient Cells Have an Altered Homeostatic Equilibrium due to Translational Inefficiency Which Explains their Reduced Fitness and Provides a Logical Framework for Intervention 2017 ·PLoS Genetics ·Piera Calamita, Annarita Miluzio, (unknown), Elisa Pesce, Sara Ricciardi, Farhat L. Khanim, Cristina Cheroni, Roberta Alfieri, Marilena Mancino, Chiara Gorrini, Grazisa Rossetti, Ivana Peluso, Massimiliano Pagani, Diego L. Medina, Johanna M. Rommens, Stefano Biffo	30
11	Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations 2015 ·Molecular Cancer Therapeutics ·Mara Bonelli, Andrea Cavazzoni, Francesca Saccani, Roberta Alfieri, Federico Quaini, Silvia La Monica, Maricla Galetti, Daniele Cretella, Cristina Caffarra, Denise Madeddu, Caterina Frati, Costanza Annamaria Lagrasta, Angela Falco, (unknown), Claudia Fumarola, Marcello Tiseo, Pier Giorgio Petronini, Andrea Ardizzoni	32
12	Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer breakdown → 2014 ·Biochemical Pharmacology ·Claudia Fumarola, Mara Bonelli, Pier Giorgio Petronini, Roberta Alfieri	390
13	Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer 2013 ·Neoplasia ·Elena Galvani, Elisa Giovannetti, Francesca Saccani, Andrea Cavazzoni, Leticia G. León, Henk Dekker, Roberta Alfieri, Caterina Carmi, Marco Mor, Andrea Ardizzoni, Pier Giorgio Petronini, Godefridus J. Peters	13
14	Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines 2011 ·Molecular Cancer ·Roberta Alfieri, Maricla Galetti, (unknown), Roberta Andreoli, Paola Mozzoni, Andrea Cavazzoni, Mara Bonelli, Claudia Fumarola, Silvia La Monica, Elena Galvani, Giuseppe De Palma, Antonio Mutti, Marco Mor, Marcello Tiseo, E. Mari, Andrea Ardizzoni, Pier Giorgio Petronini	37
15	TRAIL‐induced apoptosis of FHIT‐negative lung cancer cells is inhibited by FHIT re‐expression 2009 ·Journal of Cellular Physiology ·Prisco Mirandola, Giuliana Gobbi, (unknown), Chiara Malinverno, Andrea Cavazzoni, Roberta Alfieri, Pier Giorgio Petronini, Marco Vitale	2
16	Anti-proliferative effect of combining Letrozole with Sorafenib in MCF-7/Arom-1 breast cancer cells 2008 ·Cancer Research ·Mara Bonelli, Claudia Fumarola, Roberta Alfieri, Rita Gatti, Silvana Belletti, Silvia La Monica, Maricla Galetti, Andrea Cavazzoni, (unknown), Alberto Bottini, (unknown), Mark Lynch, Adrian L. Harris, Stephen B. Fox, Daniele Generali	1
17	Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress 2006 ·The Journal of Physiology ·Roberta Alfieri, Mara Bonelli, Andrea Cavazzoni, Maurizio Brigotti, Claudia Fumarola, Piero Sestili, Paola Mozzoni, Giuseppe De Palma, Antonio Mutti, Domenica Carnicelli, Federica Vacondio, Claudia Silva, Angelo F. Borghetti, Kenneth P. Wheeler, Pier Giorgio Petronini	57
18	The effect of trehalose on human lung fibroblasts stored in euro-collins and low potassium dextran solutions. 1997 ·PubMed ·Paolo Carbognani, (unknown), Lorenzo Spaggiari, Piergiorgio Solli, Roberta Alfieri, L Cattelani, Antonio Bobbio, (unknown)	2
19	Cell susceptibility to apoptosis by glutamine deprivation and rescue: Survival and apoptotic death in cultured lymphoma-leukemia cell lines 1996 ·Journal of Cellular Physiology ·Pier Giorgio Petronini, Simonetta Urbani, Roberta Alfieri, Angelo F. Borghetti, Guido Guidotti	55
20	METHODOLOGY FOR THE ASSESSMENT OF LUNG PROTECTION 1995 ·Transplantation ·Lorenzo Spaggiari, Paolo Carbognani, Michele Rusca, Roberta Alfieri, Piergiorgio Solli, L Cattelani, Simonetta Urbani, P. G. Petronini, Angelo F. Borghetti, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact